Adaptive Biotechnologies ended 2025 with $240.2 million in cash, cash equivalents, and marketable securities. The company achieved positive Adjusted EBITDA of $4.1 million for the fourth quarter, ...

Nocturnal symptoms and musculoskeletal pain are filtered through relapse fear, driving repetitive interpretation of ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (TransCode), a clinical stage company pioneering immuno-oncology and RNA therapeutics ...

Learn how SEBI regulations shape derivatives trading in India, including position limits, intraday rules, and what they mean ...

Align Technology shares surge after Q4 EPS and revenues beat expectations, lifted by record Clear Aligner volumes, even as ...

Your daily dose of the most interesting uptrends and downtrends on the ASX with technical analysis from an expert.

Your daily dose of the most interesting uptrends and downtrends on the ASX with technical analysis from an expert.

If you're not familiar with required minimum distributions (RMDs) and their rules, it could cost you a lot. It's smart to get savvy about RMDs, even if your retirement is years away. Here's a brief ...

Objectives Female sex and anticitrullinated protein antibodies (ACPA) are associated with higher disease activity in ...

Neutral editorial coverage examining institutional commentary, healthcare sector context, and index association surrounding a respiratory medical technology provider within established United States ...

ResMed Inc. (NYSE:RMD) reported better-than-expected second-quarter earnings on Thursday, as the sleep and respiratory care device maker posted strong revenue growth a ...

US equities retreated from record highs as Microsoft suffered its worst session since 2020, losing -US$357bn in market cap ...